Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Frequently asked questions
What sector does Quantum Genomics SA (ALQGC) operate in?
Quantum Genomics SA belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Quantum Genomics SA (ALQGC) current stock price?
As of the latest data, Quantum Genomics SA stock price is €0.07, with a previous close of €0.07.
What is Quantum Genomics SA (ALQGC) current market capitalization?
Quantum Genomics SA market cap is approximately 5.02 million.
What is Quantum Genomics SA (ALQGC) Earnings Per Share (EPS)?
The trailing EPS is -€0.80.
Does Quantum Genomics SA (ALQGC) pay dividends?
No. Quantum Genomics SA does not pay a dividend.
What is Quantum Genomics SA (ALQGC) beta (volatility) score?
Quantum Genomics SA has a beta of -0.166, indicating lower volatility than the overall market.